Business Description
CytoMed Therapeutics is a Singapore-based biopharmaceutical company founded in 2018 that develops cell-based treatments for cancer and degenerative diseases across Malaysia and Singapore. Its pipeline includes several advanced therapy candidates that use the body's own immune cells ? such as gamma delta T cells and stem cells ? to target and destroy a wide range of cancers, as well as an injectable stem cell product designed to treat cartilage injuries. The company's lead cancer treatment is currently in Phase I clinical trials, and CytoMed works alongside hospital and research partners in Singapore to advance its therapies toward broader clinical use.
